Biote Corp. Class A Common Stock
$1.36
$0.01 (+0.74%)
$1.33Day Range$1.40
Key Statistics
Market Cap
$39.00M
Shares Outstanding
28.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 27, 2022
Round Lot
100
Locale
US
Trading Data
Day Open
$1.35
Day High
$1.40
Day Low
$1.33
Volume
147.4K
VWAP
$1.36
Prev Close
$1.35
Transactions
--
Acc. Volume
--
About Biote Corp. Class A Common Stock
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
MEDICINAL CHEMICALS & BOTANICAL PRODUCTSSIC 2833223 employees1875 W. WALNUT HILL LN #100, IRVING, TX, 75038972-486-9346IPO May 27, 2022US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001819253
- Composite FIGI
- BBG00ZCMCB75
- Share Class FIGI
- BBG00ZCMCC37
- Ticker Root
- BTMD
- SIC Code
- 2833
About Biote Corp. Class A Common Stock (BTMD) Stock
Biote Corp. Class A Common Stock (BTMD) closed the 2026-09-18 session at $1.36, up 0.74% versus the previous close (+0.01). The stock opened at $1.35 and traded between $1.33 and $1.40 during that session. Session trading volume was 147K shares. The volume-weighted average price (VWAP) is $1.36.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Biote Corp. Class A Common Stock has a market capitalization of $39.0 million. The company operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry classification. BTMD is listed on the XNAS exchange. The company employs approximately 223 people. Biote Corp. Class A Common Stock is headquartered in IRVING, TX. The recorded listing date is 2022-05-27.
On this page you can find market BTMD stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector.